mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.1 |
0.02 |